The free radical scavenger N-Tert-Butyl-&#945;-Phenylnitrone (PBN) administered to immature rats during status epilepticus alters neurogenesis and has variable effects, both beneficial and detrimental, on long-term outcomes by Kubov&#225 et al.
ORIGINAL RESEARCH
published: 28 August 2018
doi: 10.3389/fncel.2018.00266
The Free Radical Scavenger
N-Tert-Butyl-α-Phenylnitrone (PBN)
Administered to Immature Rats
During Status Epilepticus Alters
Neurogenesis and Has Variable
Effects, Both Beneficial and
Detrimental, on Long-Term
Outcomes
Hana Kubová 1*, Jaroslava Folbergrová 1, Jana Rejchrtová 1, Grygoriy Tsenov 1,
Martina Parˇízková1, James Burchfiel 2, Anna Mikulecká 1 and Pavel Maresˇ1
1Department of Developmental Epileptology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czechia,
2Strong Epilepsy Center, Department of Neurology, University of Rochester Medical Center, Rochester, NY, United States
Edited by:
Antonio Gambardella,
Università degli Studi Magna Græcia
di Catanzaro, Italy
Reviewed by:
Roberta Monterazzo Cysneiros,
Mackenzie Presbyterian University,
Brazil
Luiz E. Mello,
Federal University of São Paulo, Brazil
*Correspondence:
Hana Kubová
kubova@biomed.cas.cz
Received: 21 March 2018
Accepted: 02 August 2018
Published: 28 August 2018
Citation:
Kubová H, Folbergrová J,
Rejchrtová J, Tsenov G, Parˇízková M,
Burchfiel J, Mikulecká A and Maresˇ P
(2018) The Free Radical Scavenger
N-Tert-Butyl-α-Phenylnitrone (PBN)
Administered to Immature Rats
During Status Epilepticus Alters
Neurogenesis and Has Variable
Effects, Both Beneficial and
Detrimental, on Long-Term
Outcomes.
Front. Cell. Neurosci. 12:266.
doi: 10.3389/fncel.2018.00266
Status epilepticus (SE), especially in immature animals, is known to produce recurrent
spontaneous seizures and behavioral comorbidities later in life. The cause of these
adverse long-term outcomes is unknown, but it has been hypothesized that free radicals
produced by SE may play a role. We tested this hypothesis by treating immature (P25)
rats with the free radical scavenger N-tert-butyl-α-phenylnitrone (PBN) at the time of
lithium chloride (LiCl)/pilocarpine (PILO)-induced SE. Later, long-term outcomes were
assessed. Cognitive impairment (spatial memory) was tested in the Morris water maze
(MWM). Emotional disturbances were assessed by the capture test (aggressiveness)
and elevated plus maze’s (EPM) test (anxiety). Next, the presence and severity of
spontaneous seizures were assessed by continuous video/EEG monitoring for 5 days.
Finally, immunochemistry, stereology and morphology were used to assess the effects
of PBN on hippocampal neuropathology and neurogenesis. PBN treatment modified
the long-term effects of SE in varying ways, some beneficial and some detrimental.
Beneficially, PBN protected against severe anatomical damage in the hippocampus and
associated spatial memory impairment. Detrimentally, PBN treated animals had more
severe seizures later in life. PBN also made animals more aggressive and more anxious.
Correlating with these detrimental long-term outcomes, PBN significantly modified
post-natal neurogenesis. Treated animals had significantly increased numbers of mature
granule cells (GCs) ectopically located in the dentate hilus (DH). These results raise the
Abbreviations: DCX, doublecortin; EPM, elevated plus maze; MWM, Morris water maze; NeuN, neuronal specific nuclear
protein; PBN, N-tert-butyl-α-phenylnitrone; PILO, pilocarpine; Prox-1, prospero-like homeobox protein 1; TLE, temporal
lobe epilepsy.
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possibility that abnormal neurogenesis may significantly contribute to the development
of post-SE epilepsy and behavioral comorbidities.
Keywords: juvenile rats, epilepsy, epileptic comorbidities, adult neurogenesis, free radical scavenger,
neuroprotection
INTRODUCTION
It is well known that status epilepticus (SE) results in the
development of recurrent seizures and behavioral comorbidities.
Researchers have identified numerous changes in the brain
following SE that may contribute to these outcomes. Prominent
among these changes are neuropathological modifications within
the hippocampus, including the loss of specific neuronal
populations and abnormal neurogenesis, especially the aberrant
migration of newborn granule cell (GC) neurons to the dentate
hilus (DH).
The mechanisms underlying these neuropathological
changes, however, remain largely unknown. Recently,
increased attention has been paid to the role of free radicals in
epileptogenesis. Seizures are known to produce excessive free
radicals, which in turn can substantially contribute to seizure-
induced neuronal damage in both adult (Bruce and Baudry,
1995; Ueda et al., 2002) and developing animals (Patel and Li,
2003; Folbergrová et al., 2006, 2016).
If free radicals play a role in neuropathological damage
following SE, then it follows that neutralizing these agents
during SE might be able to reverse or substantially ameliorate
this damage. We tested this hypothesis using the free radical
scavenger N-tert-butyl-α-phenylnitrone (PBN). We chose this
agent because of its demonstrated acute neuroprotective effects
in many neurodegenerative models (for review see Hensley
et al., 1997) including different seizure models in both adult
(He et al., 1997; Folbergrová et al., 1999) and immature
(Folbergrová et al., 2006) rats. Past studies from our laboratory
have had similar results. Juvenile (P25) rats treated with
PBN during lithium chloride (LiCl)/pilocarpine (PILO)-induced
SE demonstrated a decrease of acute neurodegeneration in
several hippocampal areas and improvement of functional
recovery after SE (Rejchrtová et al., 2005). It is not known,
however, whether these short-term favorable outcomes are
permanent.
The aim of the present study was to investigate the long
term outcomes following PBN administration at the time of
SE in juvenile rats. We looked at the effect of this treatment
on the development of chronic epilepsy later in life and on
behavioral co-morbidities. We began with the hypothesis that
PBN treatment would provide long-lasting protection.
As sometimes occurs in scientific investigation, our results
were surprising. Instead of the neuroprotective effects seen
acutely, PBN’s long-term effects were mixed. PBN significantly
ameliorated some of the long-term harmful effects of SE,
but exacerbated other effects, most notably chronic seizures.
Moreover, we found an intriguing correlation between this
exacerbation of chronic epilepsy and aberrant neurogenesis in
the hippocampus. This finding provides major support for a
new hypothesis that aberrant neurogenesis may be a significant
mechanism underlying the development of chronic epilepsy
following SE.
MATERIALS AND METHODS
Animals
Experiments were performed in male Wistar albino rats
(Institute of Physiology of the Czech Academy of Sciences). The
day of birth was defined as day 0 and animals were weaned at
P21. Rats were housed in a controlled environment (temperature
22 ± 1◦C, humidity 50%–60%, lights on 6 am–6 pm) with
free access to food and water. All procedures involving
animals and their care were conducted according to the
ARRIVE guidelines1 in compliance with national (Act No
246/1992 Coll.) and international laws and policies (EU
Directive 2010/63/EU for animal experiments and the
National Institutes of Health guide for the care and use of
Laboratory animals (NIH Publications No. 8023, revised
1978). The experimental protocol was approved by the Ethical
Committee of the Czech Academy of Sciences (Approval No.
128/2013).
Induction of Status Epilepticus
The animals were pretreated at 24 days of age (P24) with LiCl
127 mg/kg i.p. Each animal was assigned a code, so its individual
history could be maintained throughout the entire study. The
next day (P25), SE was induced by a single dose of PILO
40 mg/kg i.p.
The onset of SE was defined as the appearance of clonic
motor seizures. In order to decrease mortality, a single dose
of paraldehyde (0.3 ml/kg i.p.; Fluka Chemie AG, Buchs,
Switzerland) was injected 2 h after the onset of SE (for details
see Kubová et al., 2005).
The latency to the onset of motor seizures and mortality
were recorded. Only rats that exhibited behavioral manifestations
of seizures progressing to forelimb clonus for at least 1 h,
without periods of wild running and generalized tonic-clonic
seizures, were used for further studies. It was important that the
experimental groups had this uniform level of SE severity because
our previous study (Rejchrtová et al., 2005) demonstrated that
PBN pretreatment suppresses the progression to generalized
tonic clonic seizures.
After paraldehyde injection, the rats were subcutaneously
injected with 0.9% NaCl (up to 3% of the body weight divided
into 2–3 doses) to restore volume loss. For about 3–4 days
after SE, animals were fed a moist diet. Their health status was
monitored daily until the end of study.
1https://www.nc3rs.org.uk/arrive-guidelines
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Treatment
PBN (#B/7263-5G, Sigma Chemical Co., St. Louis, MO, USA)
was administered at a total dose of 200 mg/kg, i.p. (freshly
dissolved in saline, 10 mg/ml), divided into two consecutive doses
as detailed below. This regimen is based on previous studies by
others (Kotake, 1999) and our own experience (Rejchrtová et al.,
2005).
Treatment Groups
• SE group (n = 12): these animals were subjected to PILO
induced SE without PBN treatment. Instead of PBN, these
animals received a corresponding volume of saline.
• PBN/PILO group (n = 10): these animals received two doses
of PBN (100 mg/kg i.p. each) in association with PILO:
one 30 min prior to PILO and the other 1 min after
SE onset.
• PILO/PBN group (n = 13): these animals also received
two doses of PBN (100 mg/kg i.p. each) in association with
PILO, but the timing was different from the PBN/PILO group.
The first dose was given 1 min after SE onset and the other
60 min later.
Control Groups
• C group (n = 10): these animals received the same
treatment as animals in the SE group except that PILO was
replaced with an equal volume of saline. Comparison of
this group to the SE group determined the effects of SE
alone.
• PBN group (n = 10): these animals also received an
equal volume of saline instead of PILO. Otherwise the
treatment was the same as in PBN treated animals
exposed to SE. Comparison of this group to the animals
treated with PBN and SE determined the effects of PBN
alone.
The experimental design of the study for these groups is
illustrated in Figure 1.
Assessment of Behavioral Parameters in
Adulthood
Behavioral testing of each animal was started 3 months after
SE. For the elevated plus maze (EPM) and the Morris water
maze (MWM), testing was done in a special room with constant
temperature (22 ± 1◦C) and light conditions. Before testing,
animals were allowed to adapt to the testing room for at least 2 h.
All tests were performed between 10:00 h and 14:00 h. Behavior
of the animals during testing was video recorded and analyzed
off-line by two experienced observers.
Elevated Plus Maze
Anxiety was assessed using the EPM (Figure 2A). For details see
Kubová et al. (2004). Briefly, at the beginning of the experiment,
the rat was placed onto the central square facing an open arm
and was allowed to freely explore the maze for 5 min. The rat
was considered to have entered an arm when all four limbs
were inside the arm. The time spent in open or enclosed arms,
respectively, was recorded. The level of anxiety (anxiety index)
was calculated for each animal as the percentage of time spent in
the open arms.
Resistance to Capture
Aggressiveness was assessed by resistance to capture. This test
was performed before the first training session in the MWM.
The test took place in the animal room as the rats were being
transferred to new cages for transport to the room containing
the water pool. It should be noted that about 1 week previously
the animals had been handled during testing in the EPM. At that
time, the animals were housed in their home cages in the testing
room, and they were moved gently to the maze by holding them
by the tail.
FIGURE 1 | Experimental design. Status epilepticus (SE) was induced at P25. Three months later, the animals were administered behavioral tests in two blocks:
(1) elevated plus maze (EPM) and (2) resistance to capture and Morris water maze (MWM). After each block, the animals were allowed to rest for 5–7 days. Next,
electrodes were implanted in the hippocampus and cerebral cortex of the left hemisphere followed by 1 week of recovery. Then, they underwent continuous
video/EEG monitoring for 5–7 days. Lastly, the animals were perfused for histology.
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FIGURE 2 | Long term effect of N-tert-butyl-α-phenylnitrone (PBN) treatment on behavior in the EPM. (A) Schematic of the EPM. (B) Anxiety index scores for
individual animals in each group. Individual values are plotted over box plots (median with 25%–75%) with whiskers indicating minimal and maximal values. SE
increases the anxiety index (i.e., percentage of time spent in open arms) and this effect is reversed by PBN. The PBN+SE animals actually appear to be more anxious
with most of them clustering at or near the maximum score. (Abbreviations: C, control group receiving neither SE nor PBN; PBN, control group receiving PBN but not
SE; SE, experimental group receiving only SE; and PBN+SE, experimental group treated with PBN at the time of SE. Symbols: Blue circles—C, dark blue
squares—PBN, white triangles—SE, red triangles—PBN+SE).
Resistance to capture was assessed in a single trial during
which the animals were grasped around the chest. Each animal
was assigned a score reflecting its most severe behavioral reaction
according to the following scale (adapted from Pinel et al., 1977):
1 - Remains calm when grasped—easy to handle;
2 - Avoids hand by running—resists capture;
3 - Hyperactivity—leaps to avoid capture, and struggles
vigorously when captured;
4 - Extreme hyperactivity—leaps, struggles and bites when
captured, aggressive toward siblings sharing home cage
(i.e., necessary to house animals individually).
Morris Water Maze
Spatial memory was assessed in the MWM. The parameters of the
water maze are illustrated in Figure 4A. The method has been
detailed previously (Kubová et al., 2004). The escape platform
was placed 1 cm below the water surface and its position was kept
the same throughout the experiment.
Each rat received one training session (eight 60 s trials) per
day for five consecutive days. The escape latency was measured
for each trial. If the animal failed to find the escape platform, the
trial was recorded as a failure and given a latency of 60 s.
To characterize the best performance reached by each animal,
a cumulative latency was calculated by adding all latencies from
days 3, 4 and 5. At this point all groups had reached asymptotic
performance.
Video/EEG Monitoring of Spontaneous
Seizure Activity in Adulthood
After behavioral testing was finished (approximately 4 months
after SE), an epidural silver ball electrode (AP = 0; L = 2.5 mm)
and an intrahippocampal stainless steel electrode (AP = −3.5;
L = 3; H = 3.5 mm) were implanted as described before
(Kubová and Mareš, 2013) into the left hemisphere. The
right hemisphere was preserved for later histological analyses.
Animals were allowed to recover for about 1 week and
then video/EEG was monitored continuously (24 h/day) for
5–7 days.
Video/EEG recording and off-line analyses were performed
as described previously (for details see Kubová et al., 2004).
An electrical seizure was defined as an episode of at least 5 s
of rhythmic sharp elements. The following parameters were
measured: (1) the mean number of ictal electrographic seizures
per 24 h (seizure frequency); (2) the mean seizure duration;
and (3) the total amount of time spent in seizures per 24 h
(seizure activity). For every electrical seizure, the corresponding
video recording was checked for the presence of convulsions.
Recordings were analyzed by two experienced professionals.
In addition to formal video/EEG monitoring, throughout the
study, animals were observed daily for up to 30 min during
regular checks of their status in the animal room. Any behavioral
seizures seen during these times were noted.
Histology
Within 1 week after completing the video/EEG monitoring,
rats were overdosed with an intraperitoneal injection of
urethane (2 g/kg, Sigma Chemicals), transcardially perfused
with 4% paraformaldehyde and processed for histology as
described before (for details see Kubová et al., 2004). Adjacent
series of frozen sections (1-in-5, 50 µm) were used for the
following: (1) cresyl violet staining; (2) immunohistochemistry
for doublecortin (DCX); (3) immunohistochemistry for
prospero-like homeobox protein 1 (Prox1); and (4) double-label
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immunohistochemistry to detect co-localization of Prox1 and
the neuronal specific nuclear protein (NeuN).
Assessment of Hippocampal Morphology
in Adulthood
Analysis of hippocampal morphology was performed using
methods previously described and verified with magnetic
resonance imaging (MRI; Nairismägi et al., 2006). Briefly, to
assess hippocampal thickness, a stack of three consecutive cresyl
violet stained sections (250 µm apart) was used for analysis.
Measurements were started at the level corresponding to antero-
posterior level−3.30 from Bregma according to the rat brain atlas
of Paxinos and Watson (1986). Three lines were drawn between
the alveus and the ventral surface of the infrapyramidal molecular
layer (Figure 6A). The length of each line defined the thickness
of the hippocampus at that point. This process was repeated for
each of the three sections. The mean of all measurements per
animal was calculated and used for statistical analysis.
CA1 thickness was measured separately as the distance
between the alveus and the hippocampal fissure with lines
drawn adjacent to those used for measurement of hippocampal
thickness (Figure 6A).
The volume of the hippocampus (except for the pre- and
parasubiculum) was estimated stereologically using all Nissl
stained sections containing the hippocampal formation (250 µm
apart). The method, based on the Cavalieri principle (Gundersen
et al., 1988), has been described in detail previously (Kubová
and Mareš, 2013). For each animal, the coefficient of error
(CE) was calculated to assure sufficient accuracy of the estimate
(CE< 0.05).
Assessment of Hippocampal
Neurogenesis in Adulthood
Neurons were counted stereologically using optical fractionators
(MBF Bioscience, Williston, VT, USA), as described before
(Kubová and Mareš, 2013). Counting was performed with a
100× oil immersion objective lens. The sections were randomly
selected, beginning at the level corresponding to antero-posterior
level −3.30 mm from Bregma (Paxinos and Watson, 1986)
and continuing through the whole rostro-caudal extent of the
hippocampus. The counting frame grid was applied randomly.
The thickness of the slices was measured with each count.
‘‘Guard zones’’ of 2 µm were used to avoid abnormalities of
the tissue surface (Dorph-Petersen et al., 2001). Only neurons
that came into focus by passing from one optical plane to the
next were counted. The cell counts were then calculated using
the fractionator formula, taking into account section, area and
thickness of sampling fractions (West et al., 1991). The area
of the counting frames was slightly modified for each staining
according to a preliminary test (see details below).
The number of hilar neurons (mossy cells and interneurons)
was estimated in 10 Nissl-stained sections of the dorsal
hippocampus using counting frames with an area of 1,444 µm2
and 104-µm x and y steps as described before (Kubová and
Mareš, 2013).
For counting immunostained cells, the area of the counting
frame was slightly modified for each staining based on the results
of preliminary tests.
DCX Labeled Cells
Newborn neurons were detected with an antibody against DCX
(goat polyclonal, dilution 1:500, detects C-terminus of DCX;
Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA), using the
avidin-biotin method described previously in detail (Tuunanen
et al., 1996).
The number of cells expressing DCX (DCX-ir cells) was
assessed in the dentate GC layer (GCL) plus the dentate
subgranular zone (SGZ), a region about two cells thick extending
from the inner margin of the GCL. In addition, DCX-ir cells were
assessed separately in the DH. The counting frame had an area of
2,500 µm2 and 64-µm x and y steps were used.
Prox1 Labeled Cells and Prox1/Neun Double Labeled
Cells
To identify ectopic cells in the DH, sections were processed
using nickel-enhanced diaminobenzidine peroxidase
immunohistochemistry with an antibody raised against Prox1
(1:25,000; rabbit anti-Prox1 polyclonal antibody, Chemicon
International Inc., Temecula, CA, USA) as described before
(McCloskey et al., 2006). Prox1/NeuN double-labeling was
performed following the method described by Myers et al.
(2013).
The numbers of cells expressing Prox1 (Prox1-ir cells) and
both Prox1 and NeuN (Prox1/NeuN-ir cells) were assessed in
10 sections using the method described by McCloskey et al.
(2006). The neuronal number was determined using a counting
frame of 1,600 µm2 and 104 µm x and y steps. GCs were defined
as homogeneously darkly labeled spheres. Cells were counted
as double-labeled only if they met the two following criteria:
(1) the Prox1 positive nucleus and NeuN positive cytoplasm were
brought into focus simultaneously at 100× magnification; and
(2) the cytoplasm was clearly distinguishable. These criteria are
demonstrated in Figure 8 and have been reported before (Myers
et al., 2013).
Statistical Analysis
Sample size was determined in advance according to previous
experience with the given model and followed the principles
of the three R’s (Replacement, Reduction and Refinement2).
Outcome measures and statistical tests were prospectively
selected. At the beginning of the study, a simple randomization
was used to assign each animal to a particular treatment group.
Data acquisition and analysis were done blinded to the treatment.
The data were analyzed using GraphPad Prism 7 (GraphPad
Software, La Jolla, CA, USA) software. Using the D’Agostino
and Pearson normality test, all data sets were first analyzed to
determine if the values are derived from a Gaussian distribution.
Based on these results, it was determined whether to use
nonparametric or parametric statistical methods.
The following statistical methods were used for the analysis
of seizure parameters: comparison between the SE and PBN+SE
2https://www.nc3rs.org.uk/the-3rs
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groups was done using the non-parametric Mann-Whitney test.
Comparison between PBN/PILO and PILO/PBN groups was
done using the unpaired t-test. Multiple comparisons among
all four groups were done using either the nonparametric
Kruskal-Wallis test (H (number of groups) value and p value)
followed by Dunn’s post hoc test or parametric one-way analysis
of variance (ANOVA; F (DFn, DFd) value and p value) followed
by Holm-Sidlak post hoc test. Comparison of the incidence of
generalized tonic-clonic seizures during SE between the SE and
PBN+SE groups was done using Fisher’s exact test. A p value of
less than 0.05 was considered significant.
For analyzing the anxiety index, the resistance to capture,
hippocampal volume and the number of DCX-ir cells, multiple
comparisons among all four groups were done using the
nonparametric Kruskal-Wallis test (H (number of groups) value
and p value) followed by Dunn’s post hoc test.
To analyze hippocampal thickness, CA1 thickness, the
number of hilar neurons, Prox1-ir cells and Prox1/NeuN-ir cells,
multiple comparisons among all four groups were done with
parametric one-way ANOVA (F (DFn, DFd) value and p value)
followed by Holm-Sidlak post hoc test.
The data sets from the MWM test were analyzed by two-way
repeated-measure ANOVA with one treatment factor (control,
PBN, SE and SE+PBN) and session as a repeated-measure factor
(five sessions). The post hoc Student-Newman-Keuls Method
was used to analyze the latencies to reach the platform and the
number of errors for each individual session. Data were analyzed
using SigmaStatr (SPSS Inc., Chicago, IL, USA) software. The
level of significance was set at p< 0.05.
In the text, parametric data are presented as mean± standard
deviation (SD) and non-parametric data are presented as
median with 25–75 percentile. In the graphs, parametric data
are presented in bar graphs with error bars indicating SD.
Nonparametric data are presented in box plots (median with
25–75 percentile) with whiskers indicating minimal and maximal
values and symbols indicating values for each subject. In the
figure legends, details are given concerning which tests were used
and their results.
RESULTS
PBN/PILO and PILO/PBN Groups
Statistical analysis revealed no difference between the PILO/PBN
and PBN/PILO treatments in any measurement (Supplementary
Table S1). Therefore, in the ensuing results, data from these two
groups have been combined into a single group labeled PBN+SE.
In addition, for technical reasons, some animals were lacking
data for one or more of the behavioral, electrophysiological or
anatomical studies presented below. The absence of these data
is reflected in the numbers of animals presented in the various
sections of the results.
Status Epilepticus
The parameters of SE were not significantly affected by PBN
treatment. In the SE group, all 12 animals developed convulsive
SE. Generalized tonic-clonic seizures occurred in four rats, all of
which died. The eight surviving animals all exhibited a severity
score of 3. The latency to SE onset was 1,185 ± 715 s. In the
PBN+SE group, SE developed in 21 of the 23 animals and, like the
untreated animals, they all had a severity score of 3. The latency
to SE onset was 1,589 ± 856 s (Mann-Whitney, U(183, 447) = 92;
p = 0.085) compared to the SE group. In contrast to the SE group,
none of PBN+SE animals died or exhibited generalized tonic-
clonic seizures (Fisher’s test two-sided; p = 0.012).
Long-Term Effects of PBN Treatment on
Behavior
Elevated Plus Maze (Figure 2)
SE animals tended to be less anxious than animals experiencing
no SE (SE vs. C or PBN in Figure 2B), spending significantly
more time in the open arms. This result was reversed by
PBN treatment (Kruskal-Wallis with Dunn’s post hoc test;
H(4) = 13.36; p = 0.0039). PBN+SE animals were significantly
more anxious than the SE animals, spending more than twice
as much time in the closed arms. Furthermore, PBN+SE
animals tended to be more anxious than controls with 8 of
the 19 PBN+SE animals never venturing into the open arms
of the maze, whereas all animals in the other groups explored
both the open and closed arms. Statistically, however, the
anxiety index of the PBN+SE group did not differ from
that of the control animals (C or PBN). This comparison,
however, is complicated by the ceiling effect among the PBN+SE
animals.
In the absence of SE, PBN treatment had no effect on the
anxiety index (C vs. PBN in Figure 2B).
Resistance to Capture (Figure 3)
PBN treatment did not reverse the effects of SE on aggressiveness.
In fact, PBN+SE animals were significantly more aggressive
than the SE animals (Kruskal-Wallis with Dunn’s multiple
comparison; H(4) = 39.22; p < 0.0001). SE animals resisted
capture more vigorously than controls, but increase of handling
score was not significant. The PBN+SE group surpassed this
level significantly (C – 1 (1, 1.25); PBN – 1 (1, 1); SE – 2
(2, 2.75); PBN+SE 4 (3, 4); Kruskal-Wallis with Dunn’s post
hoc test; H(4) = 39.22; p < 0.0001). What is even more striking
is that 10 of the 21 PBN+SE rats had a maximum handling
score of 4, while none of the animals in any of the other
groups did.
Morris Water Maze Test (Figure 4)
The most notable result of the MWM data was the inability
of the SE animals to learn the task. Their latencies and
their number of failures were essentially unchanged across
the five sessions. By contrast, both control groups readily
learned the task with improved latencies and decreased failures
across the sessions. Interestingly, animals treated with PBN
alone actually outperformed the C animals during the first two
sessions.
PBN treatment partially reversed the effects of SE. The
PBN+SE animals performed substantially better the SE animals.
From session 3 onward, they had shorter latencies (two way
repeated measure ANOVA with post hoc Kruskal-Wallis revealed
treatment (two-way ANOVA; F(3,168) = 10.68, p < 0.001),
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FIGURE 3 | Long term effect of PBN treatment on resistance to capture. SE resulted in a significant increase of aggressiveness. PBN treatment during SE produced
even greater aggressiveness. Capture scores of individual animals are plotted over box plots (median with 25%–75%) with whiskers indicating minimal and maximal
values. (Abbreviations the same as in Figure 2).
session (F(4,168) = 70.84, p < 0.001) and treatment × session
interaction (F(12,168) = 5.26, p < 0.001) effects) and fewer
failures (two way repeated measure ANOVA with post hoc
Kruskal-Wallis revealed treatment (F(3,168) = 14.75; p < 0.001),
session (F(4,168) = 63.72; p < 0.001) and treatment × session
interaction (F(12,168) = 6.22; p < 0.001) effects. On the other
hand, the PBN+SE animals did not perform as well as the PBN
controls during any session with consistently longer latencies and
more errors. In addition, the cumulative latency for the PBN+SE
group was significantly longer than that for the PBN group
(Kruskal-Wallis with Dunn’s multiple comparison; H(4) = 20.47;
p< 0.0001).
Long-Term Effects of PBN Treatment on
Seizure Parameters (Figure 5)
The results of PBN treatment on the development of chronic
epilepsy was the most surprising outcome of this study. Rather
than ameliorate the long term effects of SE, PBN treatment
actually exacerbated seizures 4–5 months after SE.
In the PBN+SE group, seizure frequency (mean number of
seizures per 24 h) was 6.1 times higher than in the SE group
(Mann-Whitney RST; U(44,127) = 16; p = 0.0441; Figure 5A). In
addition, the mean seizure duration per 24 h was significantly
longer in the PBN+SE group (Mann-Whitney RST; U(39,132) = 11;
p = 0.0114; Figure 5B). These animals also had increased
seizure activity, spending significantly more total time seizing
during a 24 h period than the SE group (Mann-Whitney RST;
U(43,128) = 15; p = 0.0346; Figure 5C). In both the PBN+SE and
the SE groups more than 80% of the seizures (90.8% and 83.1%,
respectively) had electrical seizure activity spread beyond the
hippocampus to the cerebral cortex. All of these seizures were
associated with behavioral correlates (stages 3–5 according to
Racine’s scale; Racine, 1972).
Long-Term Effects of PBN Treatment on
Morphology of the Hippocampus
(Figures 6, 7)
Administration of PBN during SE resulted in partial
protection against structural damage in the hippocampus
(Figure 6B). Untreated SE resulted in significant damage to
the hippocampus: the thickness of the septal hippocampus
was lower by 17.2% (one-way ANOVA following Holm-
Sidak’s post hoc test; F(3,37) = 7.677; p = 0.0004) and the
thickness of the CA1 was lower by 35.8%. In the PBN+SE
group, hippocampal thickness was significantly increased in
comparison to the SE group (one-way ANOVA with post
hoc Holm-Sidak’s test; F(3,37) = 16.8; p < 0.0001) and the
results in the PBN+SE animals did not differ statistically
from the PBN controls. In CA1, PBN treatment increased
hippocampal thickness in comparison to SE animals, but the
CA1 subregion in the PBN+SE animals was still significantly
thinner than in the PBN controls. Administration of PBN
alone did not affect any measured parameter of hippocampal
morphology.
PBN treatment significantly protected the hippocampus from
overall volume loss caused by SE. SE significantly reduced the
mean volume of the hippocampus by 28.7% in comparison to the
C group. The mean hippocampal volume of the PBN+SE group
was no different from that of either control group, although
the volumes varied considerably among the PBN+SE animals
(Kruskal-Wallis with post hoc Dunn’s test; H(4) 11.41; p = 0.0097;
Figure 6C).
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FIGURE 4 | Long term effect of PBN treatment on performance in the MWM. (A) Schematic of the MWM. (B) Mean latencies ± standard deviation (SD) to reach the
escape platform on each of the testing days for each animal group. SE animals were unable to learn the task. PBN treatment partially reversed this effect. PBN+SE
animals performed significantly better than SE animals but not as well as either C or PBN animals. (C) Number of unsuccessful trials on each of the 5 days of testing
for each group. Starting at day 3, animals treated with PBN during SE had significantly fewer failures than did the SE animals. Both groups, however, performed
worse than the control animals without SE. (D) Cumulative latencies to reach the escape platform (days 3–5) for individual animals in each group. Data presented as
box plots (median with 25–75 percentiles) with whiskers indicating minimal and maximal values (Abbreviations the same as in Figure 2).
Finally, PBN treatment partially protected against SE-induced
loss of hilar neurons (Figure 6D). The PBN+SE animals had
significantly more hilar neurons than the SE animals, but the
number of neurons in the PBN+SE group was still lower than
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FIGURE 5 | Long term effect of PBN treatment on seizure parameters of chronic epilepsy. Surprisingly, animals treated with PBN at the time of SE had significantly
more severe chronic epilepsy as measured by seizure frequency (A), seizure duration (B) and seizure activity (C). Data presented as box plots (median with
25–75 percentiles) with whiskers indicating minimal and maximal values. In the lower half of the figure (D) are representative examples of hippocampal EEG
recordings of seizures for SE and PBN+SE animals, respectively. Clonic motor behavior is indicated by the horizontal line above each tracing. Orienting = an intense
orienting reaction (Abbreviations the same as in Figure 2).
that of the control groups (one-way ANOVA with post hoc
Holm-Sidak’s test; F(3,37) = 14.57; p< 0.0001).
Long-Term Effects of PBN Treatment on
Hippocampal Neurogenesis
The effect of PBN treatment on aberrant neurogenesis in
the DH was another surprising outcome of the present
study. Strikingly, PBN+SE animals had significantly more
cells expressing both Prox1 and NeuN in comparison to SE
animals (Figure 8B). In both control groups, only sparse cells
co-expressing Prox1 and NeuN were observed in each evaluated
section (215 ± 31.5 in the C group and 273 ± 78.5 in the
PBN group; data expressed as mean ± SD). Following SE
alone, these numbers were significantly increased by more
than 10 times. PBN treatment at the time of SE further
increased the number of Prox1/NeuN-ir cells by 51.1% (one-
way ANOVA with post hoc Holm-Sidak’s test; F(3,37) = 27.34;
p< 0.0001).
By contrast, the number of cells expressing Prox1 alone
was not affected by PBN treatment. SE markedly increased the
number of these aberrant cells in the hilus, but the addition
of PBN did not significantly change the count. In both control
groups, only a few cells that met the criteria for Prox1-ir cells
were present in each evaluated section (500 ± 59 in the C group
and 541 ± 183 in PBN controls; data expressed as mean ± SD).
SE increased the number of these cells 25 times in the SE group
and 24 times in the PBN+SE group (one-way ANOVA with
post hoc Holm-Sidak’s test; F(3,37) = 8.208; p = 0.0003; Figure 8A).
PBN treatment also did not affect the number of newborn
cells in the hippocampus. The results were essentially the same
in SE and PBN+SE animals. In both groups, SE dramatically
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FIGURE 6 | Long term effect of PBN treatment on hippocampal neuropathology. (A) Cresyl violet stained coronal section of the hippocampus illustrating how
measurements of thickness were performed. The three blue lines [h(1) – h(3)] were used to measure overall hippocampal thickness. Adjacent red lines [CA(1) – CA(3)]
were used for measuring the thickness of the CA1 subregion. See “Materials and Methods” section for details. The other four panels show hippocampal
measurements for individual animals in each group. (B) Left panel shows that hippocampal (HC) thickness was significantly reduced by SE and this effect was
reversed by PBN treatment. Right panel shows that the thickness of the CA1 subregion was significantly reduced by SE and this effect was partially reversed by PBN
treatment. The PBN+SE group had a significantly thicker CA1 than the SE group but was still thinner than the control group. Data presented as a mean with SD. (C)
Hippocampal volume was significantly reduced by SE and this effect was reversed by PBN treatment. Data presented as box plots (median with 25–75 percentiles)
with whiskers indicating minimal and maximal values. (D) Unbiased stereological counts of neurons in the dentate hilus (DH) for individual animals in each group. The
number of neurons was significantly reduced by SE and this effect was partially reversed by PBN treatment. The number of cells in the PBN+SE group was
significantly greater than in the SE group, but was still less than in the control group. Data represented as a mean ± SD (Abbreviations the same as in Figure 2).
reduced the number of DCX-ir cells in comparison to controls
(Kruskal-Wallis with post hoc Dunn’s test; H(4) 21.27; p< 0.0001;
Figure 9A).
Furthermore, the location of DCX-ir cells was significantly
affected by SE. In both control groups, DCX-ir cells were
located exclusively in the dentate GCL and the dentate
SGZ (Figures 9CA1,A2). By contrast, significant numbers
of newborn neurons were located ectopically in the
hilus in both the SE (45%) and PBN+SE animals (33%;
Figure 9B). The remaining DCX-ir cells were located
in the SGZ. Each evaluated section usually contained
only a few DCX-ir cells in the SGZ, either isolated or
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FIGURE 7 | Long term effect of PBN treatment on hippocampal morphology. Left panels (A1–A3) show representative brightfield photomicrographs of Nissl stained
sections of the hippocampus from control, SE and PBN+SE animals, respectively. (B1–B3) Panels show higher magnifications of the CA1 subregion. (C1–C3)
Panels show higher magnifications of the DH. The regions of these magnifications are specified by the boxes in the (A) panels. In both CA1 and DH, the SE group
shows extensive neuronal loss. Note the striking cell loss caused by SE in CA1 indicated by the arrows in (B2). Significantly less damage is evident in the PBN+SE
group (B3,C3), but there are still fewer cells than in the control group.
in small clusters separated by large gaps. A substantial
number of newborn neurons, particularly those located in
the DH, were bipolar or displayed dense basal dendrites
(Figures 9CB1,B2,C1,C2).
DISCUSSION
The present study addressed the question: does free radical
scavenging protect against the harmful long-term consequences
of SE in immature animals? Surprisingly, we found that the
answer was complex.
We used PBN as a model free radical scavenger. PBN was
administered to P25 rats at the time of SE induced by LiCl/PILO.
Later in life these animals exhibited variable outcomes from this
treatment. Some were beneficial and some actually made the
effects of SE worse.
On the beneficial side, PBN treatment protected against
the structural damage in the hippocampus known to occur
as a consequence of SE (Nitecka et al., 1984; Lothman and
Bertram, 1993; Sankar et al., 1998). We have shown previously
that PBN has a significant neuroprotective effect acutely
(Rejchrtová et al., 2005) and the present results demonstrated
long-term protection, although not complete. Hippocampal
thickness, subfield CA1 thickness and hippocampal volume
were all statistically greater in PBN treated animals than in
animals subjected to SE alone. Nevertheless, the PBN+SE
animals still had a statistically thinner CA1 subsection than
control animals. Furthermore, the degree of preservation
of hippocampal structure varied widely among the treated
animals.
PBN treatment also had a beneficial effect on performance in
the MWM, but again, the preservation was only partial. PBN+SE
animals performed significantly better than animals subjected to
SE without treatment. In fact, the SE animals were completely
unable to learn the task, whereas the PBN treated animals steadily
improved their performance in the maze with each session.
Nevertheless, the PBN+SE animals were significantly slower in
learning the task than the control groups and continued to make
errors even in the final fifth session, while the controls were
error-free after the fourth session.
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FIGURE 8 | Long term effect of PBN treatment on aberrant neurogenesis in the dentate gyrus (DG). Upper panels show the results of unbiased stereological counts
of neurons in the DH for individual animals in each group. (A) Cells labeled with an antibody to prospero-like homeobox protein 1 (Prox1). Both SE and PBN+SE
animals show statistically increased numbers of Prox1-ir cells, but there is no difference between these groups. (B) Cells double-labeled with antibodies to Prox1 and
neuronal specific nuclear protein (NeuN). In contrast to cells labeled only with Prox1, the number of double-labeled cells is statistically greater in the PBN+SE animals
than in the SE animals not treated with PBN. (C) Representative photomicrographs of Prox1-ir cells ectopically located in the DH (black arrows). Only sparse Prox1-ir
cells are observed in controls (C1), whereas in animals experiencing SE, there are significantly more labeled cells (C2). (C3) shows a compactly labeled cell at higher
magnification. (D) Representative photomicrographs of aberrant cells in the DH labeled for Prox1 (brown stain) and NeuN (yellow stain). (D1) Low magnification. (D2)
Higher magnification showing cells labeled for Prox1 (black arrow) and NeuN (white arrowhead). (D3) Cells doubled-labeled for Prox1 and NeuN (white arrows). In
these double-labeled cells, the Prox1 labeling in the nucleus and the NeuN labeling in the cytoplasm come into focus in the same plane. Data represented as a
mean ± SD (Abbreviations: DH, dentate hilus; GCL, granule cell layer. Other abbreviations same as in Figure 2).
Our results support previous studies that demonstrated that
the extent of hippocampal damage correlates with the severity
of spatial memory deficits (Broadbent et al., 2004; Kubová and
Mareš, 2013; Maia et al., 2014). In addition, it has been shown
that other neuroprotective therapies that reduce hippocampal
neuronal loss also improve behavior in the MWM (Block and
Schwarz, 1997).
Our results do not support previous findings suggesting a
negative correlation between performance in the MWM and
seizure frequency (Nissinen et al., 2000; Majak and Pitkänen,
2004). The PBN treated animals in our study exhibited about six
times more seizures than the non-treated animals, but performed
significantly better at the task. It must be pointed out, however,
that seizure frequency in our study was formally assessed nearly
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FIGURE 9 | Long term effect of PBN treatment on newborn DXC-ir cells in the DG. (A) Numbers of DXC-ir cells observed in the DG of individual animals in each
group. SE, with or without PBN treatment, significantly suppressed neurogenesis. Data presented as box plots (median with 25%–75%) with whiskers indicating
minimal and maximal values. (B) Distribution of DXC-ir cells between the subgranular zone (SGZ) and the hilus of the DG. In control animals, all the cells are located
in the SGZ, while in animals receiving SE, substantial numbers of the cells are ectopically located in the hilus. (C) Representative photomicrographs of DXC-ir cells in
the DG. (A1) Control animal showing large numbers of DXC-ir cells exclusively located in the SGZ. (A2) Higher magnification of box in (A1). (B1,C1) SE animals
showing reduced numbers of DXC-ir cells that are distributed both in the SGZ and in the hilus. (B2,C2) Higher magnifications of boxes in B1 and C1, respectively,
showing that the aberrant cells in the hilus have abnormal bipolar morphology and dense basal dendrites (Abbreviations same as in Figure 2).
2 weeks after testing in the MWM. Therefore it is possible that
the occurrence of seizures was different at the time of behavioral
assessment. Nevertheless, informal observations of the animals
during behavioral testing did not give any indication of such a
discrepancy.
On the negative side, PBN treatment worsened the long term
outcome for other behavioral tests. In accord with a previous
report by Detour et al. (2005), animals undergoing SE were less
anxious than controls in the EPM. This effect was reversed by
PBN, but the treated animals were not normalized. Rather, the
behavior of PBN+SE animals was markedly different from that
of controls. The treated animals appeared to be more anxious,
with 8 of the 19 rats spending the entire test in an enclosed arm
(minimal anxiety index score of 0). This result sharply contrasted
with all the other groups where all the animals spent time in both
arms. Statistically, the PBN+SE group did not differ from either
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of the control groups, but the marked ceiling effect observed in
the PBN+SE animals complicates a statistical comparison.
The effect of PBN on aggressiveness also was negative.
In accord with previous studies (Huang et al., 2012), SE
significantly increased aggressive behaviors in the capture test.
Again, however, rather than normalizing this behavior, PBN
treatment actually exacerbated aggressive behaviors. Ten of the
21 PBN+SE animals received the maximum score of 4 in the
capture test and the remaining 11 animals scored a 3. None of
the SE animals scored a 4 and only two of eight scored a 3 with
the rest scoring a 2.
Thus, far from protecting against the long-term effects of SE
on anxiety and aggressiveness, free radical scavenging with PBN
actually produced more detrimental long-term outcomes.
Also contrary to the expectation of neuroprotection, PBN
treatment during SE had a detrimental long-term effect on the
development of chronic epilepsy. The treated animals developed
more severe epilepsy by all measures. The PBN+SE animals had
significantly increased seizure frequency, seizure duration and
seizure activity in comparison to SE animals. These results are
surprising given that previous studies targeting the removal of
reactive oxygen species (ROS) at the time of SE have not shown
such effects.
Antioxidant administration at the time of SE has
demonstrated either no effect on long-term seizure activity
(Pearson et al., 2015) or a reduction in the frequency of
spontaneous seizures at 5 months (Pauletti et al., 2017). These
studies employed different antioxidant agents as well as different
protocols for their administration in relationship to SE, which
probably accounts for the different results.
Indeed, recent studies have pointed out that ROS have
a complex relationship to epileptogenesis, perhaps involving
neuroinflammation (see McElroy et al., 2017). How and when
these processes act to influence seizure susceptibility following SE
are unknown, but they probably extend beyond the acute phase
of SE. Therefore, it is not surprising that different protocols to
attack ROS and oxidative stress can have different outcomes. An
optimal protective methodology has yet to be developed.
Regardless, to our knowledge, no study attempting to protect
against the development of epilepsy following SE by free radical
scavenging has shown long-term exacerbation of seizure activity
as we have demonstrated in the present article. The question then
arises: what mechanism might account for our present results?
Older literature explored the role of hippocampal neuronal
loss in the development of chronic epilepsy. This line of
inquiry, however, has not proven to be particularly fruitful with
controversial results. Some studies have suggested a correlation
between neuronal loss and seizure activity (for review see
Lothman and Bertram, 1993; Wasterlain et al., 1993, 1996;
Lowenstein, 1996), while other studies have failed to find any
such correlation (Sloviter, 1992; Buckmaster and Dudek, 1997;
Pitkänen et al., 2002; Zhang et al., 2002).
More recently, new lines of inquiry have suggested
that the development of chronic epilepsy following SE is
related to rewiring of hippocampal circuitry due to aberrant
neurogenesis. In particular, it has been demonstrated that
following an epileptogenic insult, such as SE, newborn cells
destined to become GC neurons do not always migrate
correctly to the GCL of the dentate gyrus (DG). Rather,
some cells migrate aberrantly into the DH (Parent et al.,
2006; Scharfman et al., 2007), where they can persist
(Jessberger et al., 2007).
Furthermore, electrophysiological studies in hippocampal
slices from rats with chronic epilepsy suggest that these ectopic
cells integrate into dentate circuitry and have a major impact
on the excitability of the hippocampal network (Scharfman
et al., 2003). They receive more excitatory inputs and promote
increased hippocampal excitability (Myers et al., 2013). On the
other hand, adult born GCs that correctly migrate to the GCL
show decreased excitability (Jakubs et al., 2006) or a maintenance
of excitability (Wood et al., 2011). Thus, the data suggest that
there are two populations of adult born GCs following SE: an
aberrant population in the hilus that induces hyperexcitability
and a normal population in the GCL that tends to restore
inhibition. The balance between these two populations may be
a major factor in determining the development of recurrent
seizures following SE.
The balance between the excitatory and inhibitory effects
induced by adult neurogenesis is likely to be very complex,
however. For example, Jung et al. (2004, 2006) showed that
treatment of animals with a cell proliferation inhibitor at the
time of an epileptogenic brain injury reduced the frequency of
spontaneous seizures later in life. On the other hand, Hosford
et al. (2016) found that GC ablation after SE reduced the
frequency of spontaneous seizures while paradoxically increasing
seizure duration. Iyengar et al. (2015) suppressed neurogenesis
before SE and showed that this treatment actually enhanced
the sensitivity to chemoconvulsant agents. Finally, Cho et al.
(2015) demonstrated that the severity of chronic epilepsy was
reduced if neurogenesis was ablated 4 weeks prior to SE, but
the same procedure done immediately before or after SE was
ineffective. These findings suggest that the degree of development
of newborn cells may be important in the relationship between
adult neurogenesis and epilepsy.
Our present findings tend to support the hypothesis that the
aberrant population of neurons occurring in the hilus following
SE may contribute significantly to the development of chronic
epilepsy. We confirmed that SE in juvenile animals leads to the
appearance of ectopic Prox1-ir GCs in the DH, and that the
number of these Prox1-ir cells correlates with the severity of
seizure activity. McCloskey et al. (2006) demonstrated a similar
positive association between the number of Prox1-ir cells in the
DH and seizure frequency in rats experiencing SE as adults.
On the other hand, the number of aberrant hilar Prox1-ir cells
was essentially the same in PBN+SE animals and SE animals,
not reflecting the increased seizure severity in the PBN+SE
group. This discrepancy means that some other factor must be
contributing to the increased seizure severity following PBN
treatment. Our data suggest that this added factor is the state of
maturity of the aberrant hilar GCs.
Prox1 is a specific marker for cells destined to become GCs but
it is expressed not only in mature neurons but also in immature
cells that are still differentiating (Torii et al., 1999). Thus, Prox-1
immunoreactivity labels a heterogeneous mixture of cells. All
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of them are in the GC line but they are at different stages of
development. To examine the state of maturity of aberrant hilar
GCs, we labeled cells with a second antibody that reacts with
NeuN, a nuclear protein that is specific for mature neurons.
Thus, we defined a subset of double-labeled mature GC neurons
aberrantly located in the hilus.
We found significantly more double-labeled neurons in
animals treated with PBN than in untreated SE animals. Thus,
PBN treatment caused a greater number of mature GC neurons
to become ectopically located in the hilus. If one postulates that
only these mature ectopic neurons are capable of functionally
integrating into hippocampal circuitry, then the greater seizure
severity of PBN+SE animals is potentially explained. The
presence of greater numbers of mature GC neurons in the DH
of PBN-treated rats would produce a greater degree of aberrant
excitatory circuitry in their hippocampi. This aberrant circuitry,
in turn, would render these animals more epileptic.
Our study also confirms the finding of Hattiangady et al.
(2004) that in the chronic epileptic state there is markedly
diminished neurogenesis in the hippocampus. We found a
dramatic decline in the production of cells expressing DCX, a
marker of neuronal progenitor cells, in SE and PBN+SE animals.
It has been estimated that DCX is expressed up to a maximum
of 12 days after the birth of newborn neurons (Rao and Shetty,
2004). Thus, the majority of the DCX-ir cells identified in our
study were born during the time of video/EEG monitoring when
it was demonstrated that the animals were having recurrent
spontaneous seizures.
It has also been suggested that this suppression of
neurogenesis plays a significant role in the maintenance of
chronic epilepsy (Hattiangady and Shetty, 2008). While these
authors acknowledge that there is no direct evidence to support
this suggestion, there are significant hints. For example, Liu
et al. (2003) have shown that ∼14% of newborn neurons in the
DG of young rats differentiate into inhibitory GABAergic cells.
Thus, the lack of neurogenesis in chronic epilepsy could result
in reduced inhibitory circuitry in the DG, removing a potential
counterbalance to the hyperexcitability produced by aberrant
circuitry in the hilus.
Furthermore, our data show a negative correlation between
the number of DCX-ir cells and seizure severity. In particular,
there were 17% fewer DCX-ir in PBN+SE animals. This
finding raises the possibility that the greater degree of seizure
activity is due not only to hyperexcitable aberrant circuitry
in the hilus, but also to a lack of counterbalancing inhibition
in the DG.
The role of aberrant neurogenesis in the behavioral and
cognitive comorbidities of chronic epilepsy is more difficult to
determine. To our knowledge, there are no direct data suggesting
an association between emotional impairment and the type of
aberrant neurogenesis we have demonstrated in the present
study. Nevertheless, there are some indirect data bearing on this
association.
Hester and Danzer (2014) reported that animals with
genetically disrupted adult neurogenesis, leading to abnormal
GCs, exhibit a variety of behavioral abnormalities, including
cognitive deficits, increased anxiety and depressive and
schizophrenic-like behavior. Other studies have demonstrated
that suppression of adult neurogenesis improves epilepsy-related
cognitive decline (Jessberger et al., 2007; Pekcec et al., 2008;
Cho et al., 2015). Furthermore, Hattiangady and Shetty (2008),
whom we cited earlier for their suggestion that suppression of
neurogenesis might play a significant role in the maintenance of
chronic epilepsy, have also suggested that a reduction of normal
neurogenesis may be important in epilepsy comorbidities.
Altered neurogenesis has also been observed in animal
models of behavioral pathology. Malberg and Duman (2003)
reported decreased neurogenesis in a model of depression.
Moreover, treatment with antidepressant medication increased
neurogenesis (Malberg et al., 2000) and suppression of
neurogenesis by stress was found to block the effects of
antidepressant therapy (Malberg and Duman, 2003).
Our own data in the present study show a strong negative
correlation between the number of Prox1/NeuN-ir cells and the
anxiety index. This finding, however, must be interpreted with
caution for two reasons. First, mathematical correlation does
not prove causality. Second, the neuronal network underlying
emotionality is very complex and involves many other structures
besides the hippocampus known to be damaged after SE
(e.g., amygdala and thalamic nuclei).
In conclusion, the present study has shown that the
administration of the free radical scavenger, PBN, during SE
in juvenile rats modifies the long-term consequences of this
insult in varying ways, both beneficial and detrimental. PBN
beneficially protected against the severe anatomical damage in
the hippocampus and associated spatial memory impairment.
On the other hand, animals treated with PBN developed more
severe epilepsy and emotional deficits later in life than did
animals that experienced SE alone. The mechanisms underlying
these effects of PBN are most likely complex, but our data
suggest the working hypothesis that a significant aspect of PBN’s
action is to modify postnatal neurogenesis in the hippocampus.
SE acutely increases neurogenesis and aberrant migration of
GCs to the DH. PBN appears to exacerbate this process. In
particular PBN results in increased numbers of mature hilar GCs
that may abnormally integrate into hippocampal circuitry and
produce both excessive excitability and behavioral comorbidities.
Concurrently, PBN also appears to exacerbate the suppression of
normal neurogenesis in the DG caused by chronic epilepsy. This
action potentially eliminates a counterbalancing inhibitory force
in the hippocampus.
Aberrant neurogenesis is a most intriguing explanation for
our findings, but it must be acknowledged that this not the
only possible mechanism. Other explanations include specific
areas of neuronal loss or damage induced by SE accompanied
by specific cell populations protected by the action of PBN as
described in some conventional antiepileptic drugs before (for
review see Pitkänen and Kubová, 2004). For example, Peterson
et al. (2005) demonstrated that PBN provided acute protection
(24 h after Li/PILO-induced SE) in parietal, occipital, perirhinal
and piriform cortices as well as lateral amygdala. By contrast,
PBN exacerbated neuropathology in CA3 and thalamus.
These widespread changes could lead to synaptic
reorganization and rewiring of the brain. Such actions may
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be especially important in juvenile animals that are in the
process of developing the balance between excitation and
inhibition and cognitive and developing cognitive and emotional
functions.
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